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Background Several parameters of cardiovascular physiology and pathophysiology exhibit circadian rhythms.
Recently, a relation between infarct size and the time of day at which it occurs has been suggested in experimental models
of myocardial infarction. The aim of this study is to investigate whether circadian rhythms could cause differences in
ischemic burden in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary
intervention (PPCI).
Methods In 353 consecutive patients with STEMI treated by PPCI, time of symptom onset, peak creatine kinase (CK), and
follow-up at 30 days were obtained. We divided 24 hours into 4 time groups based on time of symptom onset (00:00-05:59,
06:00-11:59, 12:00-17:59, and 18:00-23:59).
Results There was no difference between the groups regarding baseline patients and management's characteristics. At
multivariable analysis, there was a statistically significant difference between peak CK levels among patients with symptom
onset between 00:00 and 05:59 when compared with peak CK levels of patients with symptom onset in any other time group
(mean increase 38.4%, P b .05). Thirty-day mortality for STEMI patients with symptom onset occurring between 00:00 and
05:59 was significantly higher than any other time group (P b .05).
Conclusion This study demonstrates an independent correlation between the infarct size of STEMI patients treated by
PPCI and the time of the day at which symptoms occurred. These results suggest that time of the day should be a critical issue to
look at when assessing prognosis of patients with myocardial infarction.
Background
In mammals, many physiologic mechanisms exhibit
diurnal variations, and most of these rhythms are
independent of environmental timing cues. These
endogenous circadian rhythms are composed of intra-
cellular timing mechanisms termed circadian clocks.
The circadian clock is an evolutionarily conserved time-
keeping system that coordinates the physiology of the
organism with daily changes in the environment. The
biological clock is composed of transcriptional-transla-
tional feedback loops. In mammals, the master clock is
located in the suprachiasmatic nuclei, but most
peripheral tissues contain circadian clocks.1 These
transcriptional modulators have been identified within
the heart (cardiomyocytes, vascular smooth muscle
cells, endothelial cells, and fibroblasts)2-5 and have
been shown to regulate apoptosis, contractile function,
metabolism, and gene expression and therefore confer
the selective advantage of anticipation, permitting the
cell to respond appropriately to a stimulus at a given
time of the day.6 Recently, experimental studies have
shown that cardiomyocyte circadian clock affects the
response of the heart to various stresses including
ischemia/reperfusion by modulating multiple cardiopro-
tective signaling pathways.6,7
It is well known that onsets of adverse cardiac events,
such as sudden cardiac death,8 stroke,9 and myocardial
infarction increase from 6 AM.10 The higher incidence of
myocardial infarction during the latter part of the
morning (6 AM to noon) can be explained by the
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combination of rise in arterial blood pressure, hormonal
stimulation (β-adrenergic, cortisol),11 hyperreactivity of
platelets,12 and shear stress resulting in atherosclerotic
plaque disruption and thrombosis. If frequency of
myocardial infarction is higher during the morning,
severity of myocardial infarction in terms of infarct size
could have a different time pattern. In fact, a circadian
vulnerability variations to ischemia has just recently been
suggested with controversial results.13,14 Accordingly,
we speculate that time of the day onset of myocardial
infarction could affect ischemic burden in patients with
ST-elevation myocardial infarction (STEMI) undergoing
primary percutaneous coronary intervention (PPCI).
Method
Patient population
Between January 01, 2009, and December 31, 2010, 588
consecutive STEMI patients underwent a PPCI at the University
Hospital of Lausanne, Switzerland. Among them, patients with
symptom-to-first-medical-contact time N12 hours, patients for
whom time of symptom onset was unknown, patients with
unknown peak creatine kinase (CK) levels and patients with a
previous treatment by fibrinolysis or addressed to surgery for
coronary artery bypass graft (CABG) were excluded. A total of
353 patients were finally included (Figure 1). We divided 24
hours into 4 time groups based on time of symptom onset
(00:00-05:59, 06:00-11:59, 12:00-17:59, and 18:00-23:59). Labo-
ratory, clinical, hemodynamic, angiographic, and demographic
data were collected from the local database. Blood sampling for
CK was performed at baseline (admission) and every 4 hours
post-PCI until peak CK was reached.
Clinical follow-up
Patientswere sent awritten questionnaire to report their clinical
events. When needed, patients and/or their general practitioners
were contacted by telephone for additional information.
Statistical analysis
Expecting in the time group 00:00 to 05:59 a frequency of
myocardial infarction onset of 20% and assuming in this group
peak CK levels 40% higher than in all other time groups (06:00-
23:59), a total of 322 patients was needed to detect the expected
difference with an estimated power of 80% at a 2-side α of .05.
Statistical analysis was carried out using SPSS 15.0 software
(SPSS, Inc, Chicago, IL), and significance was defined as P b.05.
Continuous variables are expressed as mean ± SD. Categorical
variables are reported as frequencies and percentages. Student
t test or analysis of variance was used to compare continuous
variables, as appropriate. Comparisons between categorical
variables were evaluated using Pearson χ2 test. To analyze the
distribution of events over the 24-hour clock, we tested a
sinusoidal function that modeled the distribution of events
against a null hypothesis of a uniform likelihood. For multivar-
iate analysis, a multiple linear regression analysis with peak CK
levels as a continuous dependent variable was used. We
included in the multivariate analysis the comparison of time
group 00:00 to 05 :59 versus all other time groups (06:00-23:59)
as a dichotomous variable. Major demographic characteristics
were also included in the multivariate model. Kaplan-Meier
curves for survival were constructed and compared between
the 2 groups (first time group compared with all other time
groups) with the log-rank test. P b .05 was considered
statistically significant.
This study complied with the Declaration of Helsinki
regarding investigations in humans and was approved by the
Institutional Ethics Committee at the University Hospital of
Lausanne, Switzerland. The authors are solely responsible for
the design and conduct of this study, all study analyses, and
drafting and editing of the manuscript. No extramural funding
was used to support this work.
Results
Baseline clinical characteristics
Table I summarizes baseline clinical characteristics. No
difference was found among the 4 time groups, except
for the variable “prior PCI.” Of note, there was no
difference in myocardial infarction localization between
the time groups.
Management characteristics
Table II summarizes baseline management characteris-
tics. There was no difference among the 4 time groups in
terms of procedure performance. Symptom-to-PCI hospital
time or admission-to-needle time was similar between
time groups. Of note, no difference in procedure duration,
thrombolysis in myocardial infarction (TIMI) flow score at
Figure 1
Study flow chart.
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the end of the procedure, or stent characteristics was
observed between the different time groups.
Frequency distribution of STEMI symptoms onset
The frequency of myocardial infarction onset was higher
between 08:00 and 14.59 (45.3% of patients) compared
with the rest of the day (15:00-7:59). The modelized sinus
function fitted better than a null hypothesis of a uniform
likelihood (P b .001) (Figure 2). Comparing the 4 time
groups, frequency of myocardial infarction was lower in
time group 00:00 to 05:59 (17.56%) when compared with
other time groups (30.88% for time group 06:00-11:59,
31.73% for time group 12:00-17:59, and 19.83% for time
group 18:00-23:59).
Peak CK and time groups
There was a significant relationship between time of
symptom onset and peak CK levels. Creatine kinase levels
among patients with symptom onset between 0:00 and
05:59 were significantly higher than in the 3 other groups
of patients with symptom onset at any other time of the
day. Mean CK levels among patients with symptom
onset between 00:00 and 05:59 were 3484 ± 3467 versus
2507 ± 2142 versus 2533 ± 2214 versus 2508 ± 2057
for patients with symptom onset between 06:00 and
11:59, 12:00 and 17:59, and 18:00 and 23:59, respectively
(P b .05) (Figure 3A).
To exclude bias caused by “off-hours” duty, a similar
analysis was performed in patients presenting during the
Table I. Patients' clinical and angiographic characteristics
Group variable
00:00-05:59 06:00-11:59 12:00-17:59 18:00-23:59
P(n = 62) (n = 109) (n = 112) (n = 70)
Age (y), mean ± SD 64.02 ± 12.76 67.55 ± 12.1 66.38 ± 12.53 64.61 ± 13.43 .251
Male sex 51 (82%) 81 (74%) 80 (71%) 45 (64%) .133
Diabetes 13 (21%) 28 (26%) 19 (17%) 9 (13%) .16
Hypertension 29 (47%) 53 (49%) 63 (56%) 41 (59%) .371
Smoking 36 (58%) 60 (55%) 55 (49%) 36 (51%) .666
Obesity 18 (29%) 28 (26%) 29 (26%) 10 (14%) .182
Cholesterol 29 (47%) 64 (59%) 51 (46%) 32 (46%) .174
Aspirin 7 (15%) 17 (19%) 15 (15%) 14 (22%) .6291
Clopidogrel 3(6%) 7(8%) 4(4%) 4(6%) .7536
Statin 5 (10%) 14 (16%) 18 (18%) 16 (25%) .2021
β-Blockers 5 (10%) 11 (12%) 12 (12%) 9 (14%) .9422
ACE inhibitors/ARB 14 (29%) 32 (36%) 29 (29%) 21 (33%) .7807
Initial heart rate (beat/min), mean ± SD 73.26 ± 16.94 72.6 ± 14.61 77.68 ± 16.39 76.42 ± 14.68 .1729
SBP (mm Hg), mean ± SD 127.6 ± 25.87 130.3 ± 21.15 128.7 ± 21.45 120.5 ± 22.34 .0778
DBP (mm Hg ± SD) 77.18 ± 14.74 75.23 ± 12.91 79.03 ± 12.72 73.75 ± 14.12 .1201
Location of MI
Inferior 29 (47%) 45 (41%) 43 (38%) 38 (54%)
Anterior 26 (42%) 52 (48%) 59 (53%) 22 (31%)
Lateral 7 (11%) 9 (8%) 9 (8%) 9 (13%)
Prior MI 0 (0%) 6 (6%) 7 (6%) 7 (10%) .1
Prior PCI 2 (3%) 15 (14%) 5 (4%) 7 (10%) .031
Ejection fraction (%), mean ± SD 46.48 ± 11.64 46.46 ± 11.9 48.91 ± 10.94 48.57 ± 11.17 .6833
ACE, Angiotensin-converting enzyme; ARB, angiotensin II receptor blockers; SBP, systolic blood pressure; DBP, diastolic blood pressure; MI, myocardial infarction.
Table II. Management characteristics
Group variable
00:00-05:59 06:00-11:59 12:00-17:59 18:00-23:59
P(n = 62) (n = 109) (n = 112) (n = 70)
Symptom-to-PCI hospital time (min), median ± SD 189 ± 181.1 162 ± 303.6 154.5 ± 159.3 152.5 ± 219.3 .4156
Admission-to-needle time (min), median ± SD 59.72 ± 28.3 61.63 ± 40.04 60.14 ± 42.09 69.15 ± 48.21 .4994
TIMI score at end of PCI, mean ± SD 2.750 ± 0.5853 2.736 ± 0.6836 2.686 ± 0.7872 2.838 ± 0.5534 .7792
Rentrop grade, mean ± (SD) 0.57 ± 0.73 0.51 ± 0.76 0.46 ± 0.63 0.45 ± 0.74 .7063
No. of stent, mean ± SD 1.208 ± 0.4104 1.2 ± 0.4577 1.112 ± 0.3176 1.228 ± 0.4233 .288
Size of the stent (mm), mean ± SD
Length of the stent 24.29 ± 9.876 27.26 ± 13.27 26.11 ± 12.89 24.85 ± 8.003 .4924
Diameter of the stent 3.044 ± 0.5036 3.113 ± 0.5063 2.984 ± 0.6502 3.102 ± 0.6076 .4897
Procedure (PCI) duration (min), mean ± SD 67.92 ± 24.17 65.16 ± 27.93 67.76 ± 23.17 62.78 ± 26.79 .6479
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weekend. There was a statistically significant difference
between CK levels among patients with symptom onset
between 00:00 and 05:59 when compared with CK levels
of patients with symptom onset in any other time group
(4013 ± 3382 vs 2687 ± 2229 [06:00 and 11:59] vs 2309 ±
2017 [12:00 and 17:59] vs 2226 ± 1423 [18:00 and 23:59],
P b .05) (Figure 3B).
Because “symptom-to-PCI hospital time” is a variable
of utmost importance in terms of infarct size, we
calculated the ratio (peak CK/symptom-to-PCI hospital
time in minutes) for every patient of each group. There
was a statistically significant difference between mean
peak CK/symptom-to-PCI hospital time in minutes
among patients with symptom onset between 00:00
and 05:59 when compared with patients with symptom
onset in any other time group (21.79 ± 28.16 vs 13.88 ±
11.20 [06:00 and 11:59] vs 16.06 ± 14.83 [12:00 and
17:59] vs 15.39 ± 11.60 [18:00 and 23:59], P b .05)
(Figure 3C).
Multivariable analysis
Given the significant higher CK levels in time group
0:00 to 05:59 than any other time group of the day, we
performed a multiple-logistic mixed-effect regression
Figure 2
Frequency distribution of myocardial infarction onset during a 24-
hour period. A statistically significant percentage was found in the
time frame of 08:00 to 15:00(P b .05).
Figure 3
Mean peak CK levels distribution in the different time groups. A
statistically significant difference of mean peak CK levels was
observed between the time groups 00:00 to 05:59 compared with
any other time groups of the day (P b .05) (A). Similar difference was
observed either during “off-hours” duty (P b .05) (B) or when peak CK
level was balanced to “symptom-to-PCI hospital times” (P b .05) (C).
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model. This difference remained significant after multi-
variable analysis (regression coefficient 2.41, 95% CI
153.54-1513.20, log-rank P = .016) and was not explicable
by age, gender, hypertension, diabetes, cholesterol,
smoking habit, obesity, myocardial infarction localiza-
tion, previous myocardial infarction, or previous PCI.
Clinical follow-up
Follow-up at 30 days was obtained in 94.9% of the
population. There was no significant difference in the in-
hospital mortality rate among the 4 time groups. We
observed 16 in-hospital deaths (4.53%): 6 deaths (9.68%)
occurred in the time group 00:00 to 05:59, 4 (3.67%) in
the time group 06:00 to 11:59, 5 (4.46%) in the time
group 12:00 to 17:59, and 1 (1.43%) in the time group
18:00 to 23:59 (P = .1363). However, there was a
significant difference in the mortality rate at 30 days
among the 4 time groups. We observed 20 deaths at 30
days (5.97%): 7 (11.48%) deaths occurred in the time
group 0:00 to 05:59, 5 (4.95%) for the time group 06:00 to
11:59, 6 (5.66%) for the time group 12:00 to 17:59, and 2
(2.99%) for the time group 18:00 to 23:59. The Kaplan-
Meier percentage survival estimates at 30 days were
88.53% in the time group 00:00 to 05:59 and 95.26% in
the other time group (P b .05) (Figure 4).
Discussion
In this study, conducted in 353 consecutive patients
with STEMI undergoing PPCI, we observed a circadian
variation in peak CK after myocardial infarction, a
surrogate of myocardial infarct size. Infarct size was
higher in patients with symptom onset during the period
between 00:00 and 05:59, and this was independent of
baseline clinical or management variables. In addition, we
observed a higher mortality rate at 30 days among the
group of patients with symptom onset between 00:00
and 05:59.
Knowing the time of the day is a key issue for any
organism, allowing it to react appropriately to all sorts
of stress. Indeed, the demands placed on an organism
fluctuate dramatically over the course of the day, and
anticipation regarding these demands gives a selective
advantage, allowing the organism to react before the
stimuli occur. Cellular mechanisms exist in the cardio-
vascular system, like in every eukaryote cell, that
orchestrate oscillation of tissue function during a 24-
hour period. For instance, experimental studies have
shown that cardiac redox status and fatty acid metab-
olism,6,15 but also myocardial contractile function, are
regulated in a circadian manner.16 It is therefore
tempting to wonder whether ischemic stress would
have a different impact on the myocardium over a 24-
hour period. Recent studies have shown a profound
effect of time of the day on ischemic burden in mouse
models of myocardial infarction.7,17 In addition, these
results were blunted in mouse models, genetically
modified at the level of the circadian clock mecha-
nism.7,17 Evidence of such regulation mechanism in
humans is sparse and controversial.13,14 Holmes et al13
assessed the circadian variation of symptom onset and
in-hospital mortality in 2,143 patients with STEMI. The
authors found a significant association between time of
symptom onset and circadian cycle, with the greatest
percentage of patients with symptom onset between
08:00 and 15:00. Our results are in line with the results
from Holmes et al. In the present study, we found a
significant percentage of patients with symptom onset
between 08:00 and 15:00 (45.3% vs 39% in Holmes'
study). If symptom onset arises more frequently
between 08:00 and 15:00, ischemic burden caused by
vascular obstruction might have a different variation
over a 24-hour period. This issue has been assessed in
the study of Holmes et al, where the authors found a
nonsignificant trend of higher in-hospital mortality
between 00:00 and 05:59 and also between 18:00 and
23:59 after multivariable adjustment. Indeed, Holmes et
al found a higher prehospital delay time in the time
group 00:00 to 05:59 (121 minutes vs 70-83 minutes for
the other time groups), which creates an inherent bias
although these variables were included in the statistical
analysis. To limit such hurdle, we limit the study to one
single center during a limited period to keep homoge-
neous management characteristics. In addition, our
population was restricted to patients having STEMI
and treated by PPCI. This diverges from the study of
Holmes et al, where N10% of patients received systemic
thrombolysis. Accordingly, these different management
characteristics observed in the study of Holmes et al
might have blunted a potentially significant higher in-
hospital mortality. On the other hand, we did not find
Figure 4
Kaplan-Meier curves showing percent survival free from death in the
time group 00:00 to 05:59 and in the other time group.
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either difference in terms of in-hospital mortality.
Indeed, we found a difference in mortality rate only at
30 days.
The study recently published from Suarez-Barrientos
et al14 assessed peak CK and troponin level as
surrogate of infarct size in 811 patients with STEMI.
The authors found a significant higher infarct size in
the time group 06:00 to 11:59 and 18:00 to 23:59 even
after multivariable adjustment. Our results are different
in terms of time at which the myocardium has
maximal vulnerability to ischemia. We found higher
peak CK in the time group 00:00 to 05:59 compared
with any time group. Of note, Suarez-Barrientos et al
observed a significant higher incidence of anterior wall
myocardial infarction in the time group of 06:00 to
11:59 and a significant lower rate of PPCI in this same
time group. These latter variables are indeed of utmost
importance in terms of infarct size. In our study, the
rate of anterior wall infarction was similar among all
time groups as well as PPCI procedure duration, stent
characteristics, and TIMI flow at the end of the
procedure. In addition, we found a higher 30-day
mortality in the time group of 00:00 to 05:59 putting
forward this period of symptom onset critical for
patients with STEMI. We certainly cannot rule out a
regional effect where a wake-up time shift would
explain the differences between the study of Suarez-
Barrientos et al and the present study.
Limitations
The number of patients included remains relatively
small, but our STEMI system of care allowed us to
obtain 4 homogeneous groups in terms of clinical
characteristics, management, and delays. In addition,
peak CK is only a surrogate of infarct size, and magnetic
resonance imaging with late gadolinium enhancement
may have given additional infarct size information. Of
note, no statistical difference in left ventricular ejection
fraction was observed among the 4 time groups at
admission, and we do not have echocardiography at
follow-up for all patients.
Conclusions
The present study shows circadian variations in
infarct size and in 30-day mortality in patients with
STEMI treated by PPCI after multivariable adjustment.
These results highlight the influence of the time of day
on the pathophysiology of myocardial infarction and
suggest that myocardium has higher vulnerability to
ischemia during the period of 00:00 to 05:59. Accord-
ingly, the time of day should be a critical issue to look
at when assessing the prognosis after STEMI.
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